Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir plus pegylated interferon in pediatric chronic hepatitis B
jRCTs051180151Completed
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of entecavir and pegylated interferon alpha in Chronic Hepatitis B (CHB). Primary endpoints: ALT normalization, HBeAg/HBeAb seroconversion and 2 more. Started Sep 2015; status: completed.
02
Drugs
entecavirpegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on jRCTs051180151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180151.